Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis

American Journal of Rhinology

Volumn 21, Issue 6, 2007, Pages 691-694

  Gonçalves, Carla ^a   Pinaffi, Juliana V ^a   Carvalho, Jozélio F ^a   Pinna, Fabio R ^a   Constantino, Guilherme T ^a   Voegels, Richard L ^a   Bueno, Cleonice ^a   Bonfá, Eloisa ^a   Viana, Vilma S T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antineutrophil antibody (ANCA); Chronic rhinosinusitis; Churg Strauss syndrome; Microscopic polyangiitis; Myeloperoxidase (MPO); Proteinase 3 (PR3); Vasculitis; Wegener's granulomatosis

Indexed keywords

BIOLOGICAL MARKER; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; ASTHMA; CHRONIC DISEASE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTAXIS; EYE PAIN; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MALE; RHINOSINUSITIS; SCORING SYSTEM; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; RHINITIS; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 38349003022     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2007.21.3092     Document Type: Article

References (24)

1. Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76-85, 1983.
2. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 116: 488-498, 1992.
3. Guillevin L, Pagnoux C, and Mouthon L. Churg-Strauss syndrome. Semin Respir Crit Care Med 25:535-545, 2004.
4. Han WK, Choi HK, Roth RM, et al. Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63:1079-1085, 2003.
5. Niles JL, McCluskey RT, Ahmad MF, et al. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74:1888-1893, 1989.
6. Falk RJ, and Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657, 1988.
7. Savige J, Davies D, Falk RJ, et al. Antineutrophil cytoplasmic antibodies and associated diseases: A review of clinical and laboratory features. Kidney Int 57:846-862, 2000.
8. Wiik AS. Clinical use of serological tests for antineutrophil cytoplasmic antibodies. What do the studies say? Rheum Dis Clin North Am 27:799-813, 2001.
9. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526-1533, 2003.
10. Lanza DC, and Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117:S1-S7, 1997.
11. Lund VJ, and Mackay IS. Staging in rhinosinusitis. Rhinology 31:183-184, 1993.
12. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101-1107, 1990.
13. Savage CO, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: Presentation, pathology, and prognosis. Q J Med 56:467-483, 1985.
14. Guillevin L, Le Thi Huong D, Godeau P, et al. Clinical findings and prognosis of polyarteritis nodosa and ChurgStrauss angiitis: A study in 165 patients. Br J Rheumatol 27:258-264, 1988.
15. Andersen-Ranberg K, Hoier-Madsen M, Wiik A, et al. High prevalence of autoantibodies among Danish centenarians. Clin Exp Immunol 138:158-163, 2004.
16. Choi HK, Merkel PA, Walker AM, et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43:405-413, 2000.
17. Choi HK, Merkel PA, Tervaert JW, et al. Alternating antineutrophil cytoplasmic antibody specificity: Drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum 42:384-388, 1999.
18. Cotch MF, Hoffman GS, Yerg DE, et al. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 39:87-92, 1996.
19. Weidebach W, Viana VS, Leon EP, et al. C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats. Clin Exp Immunol 129:54-60, 2002.
20. Frankel SK, Cosgrove GP, Fischer A, et al. Update in the diagnosis and management of pulmonary vasculitis. Chest 129:452-465, 2006.
21. Loyd G, Lund VJ, Beale T, et al. Radiology in Focus. Rhinologic changes in Wegener's granulomatosis. J Laryngol Otol 116:565-569, 2002.
22. Yang C, Talbot JM, and Hwang PH. Bony abnormalities of the paranasal sinuses in patients with Wegener's granulomatosis. Am J Rhinol 15:121-125, 2001.
23. Ara J, Mirapeix E, Rodriguez R, et al. Relationship between ANCA and disease activity in small vessel vasculitis patients with anti-MPO ANCA. Nephrol Dial Transplant 14:1667-1672, 1999.
24. Wiik A, Brimnes J, and Heegaard NH. Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases. Isr Med Assoc J 1:4-7, 1999.